Clinical Trials Directory

Trials / Unknown

UnknownNCT02306863

Whole-body Vibration as a Treatment for Parkinson's Disease

The Efficacy of Long-term Whole-body Vibration in the Treatment of Parkinson's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sun Life Financial Movement Disorders Research and Rehabilitation Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate whether whole-body vibration applied over a 12-week period is effective in treating motor symptoms of Parkinson's disease.

Detailed description

Parkinson's disease (PD) is a progressive neurodegenerative disease resulting in the loss of dopaminergic neurons projecting from the substantia nigra pars compacta to the striatum. Whole-body vibration (WBV) is potentially beneficial in treating Parkinson's disease because it has been shown to elicit effects specific to both the brain and muscular system. Animal models of PD indicate that whole-body vibration can increase striatal dopamine levels, as well as the number of dopaminergic neurons in the substantia nigra. These findings were correlated with increased levels of brain-derived neurotrophic factor. In addition to the potentially neuroplastic effects, \>20 Hz WBV has been shown to improve muscular performance. Improved muscular performance is believed to be attributed to WBV induced neuromuscular effects rather than muscle hypertrophy, with the specific mechanism defined as the tonic vibration reflex.

Conditions

Interventions

TypeNameDescription
DEVICEvibrating chairvibration provided via physioacoustic method
DEVICEsham treatmentsimulated whole-body vibration

Timeline

Start date
2015-01-01
Primary completion
2015-07-01
Completion
2015-08-01
First posted
2014-12-03
Last updated
2015-02-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02306863. Inclusion in this directory is not an endorsement.